Importantly, our data add to the field and provide direct evidence that desmosomal protein disruption associated with the PKP2 splice site mutation is driven by a loss of function (dose or amount of PKP2) mechanism over time and the progressive nature of ARVC. This evidence concerns the gene PKP2 and arrhythmogenic right ventricular cardiomyopathy.